Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This Phase 1/2 protocol is designed to collect safety, tolerability and pharmacokinetic data
of two doses of Laninamivir Octanoate in children and adolescents. The protocol will also
explore virology and efficacy endpoints.